Connect MM® – the Multiple Myeloma Disease Registry: incidence of second primary malignancies in patients treated with lenalidomide

Robert M. Rifkin, Rafat Abonour, Jatin J. Shah, Jayesh Mehta, Mohit Narang, Howard Terebelo, Cristina Gasparetto, Kathleen Toomey, James W. Hardin, Jane Jie Lu, Laurie Kenvin, Shankar Srinivasan, Robert Knight, Yasir Nagarwala, Brian G.M. Durie

Research output: Contribution to journalLetter

14 Scopus citations
Original languageEnglish (US)
Pages (from-to)2228-2231
Number of pages4
JournalLeukemia and Lymphoma
Volume57
Issue number9
DOIs
StatePublished - Sep 1 2016

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Rifkin, R. M., Abonour, R., Shah, J. J., Mehta, J., Narang, M., Terebelo, H., Gasparetto, C., Toomey, K., Hardin, J. W., Lu, J. J., Kenvin, L., Srinivasan, S., Knight, R., Nagarwala, Y., & Durie, B. G. M. (2016). Connect MM® – the Multiple Myeloma Disease Registry: incidence of second primary malignancies in patients treated with lenalidomide. Leukemia and Lymphoma, 57(9), 2228-2231. https://doi.org/10.3109/10428194.2015.1132419